Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral naloxone for opium tincture-associated constipation
IRCT20190207042648N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naloxone in drug-induced constipation (3 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Constipation score, Withdrawal scoring and 1 more. Started May 2021; status: completed.
02
Drugs
naloxone
03
Conditions
drug-induced constipation
Beyond the preview
Go deeper on IRCT20190207042648N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190207042648N3.